Significant variation was seen in the magnitude of weight loss and glycemic control both (i) between treatment and control cohorts when stratified by indication, age, sex and race/ethnicity, and (ii) within the GLP-1 treatment cohort itself, as shown by the stark differences between the top and bottom 10% of responders
The ASC specks were counted in a semi-automated manner using FIJI software (ImageJ, version 2.9.0/1.53t), that recognized the brightness, size and shape of the ASC specks
Understanding the Five Major Metabolic Peptides These therapies can be divided into three broad categories: Fat mobilization AOD-9604 Metabolic optimization MOTS-c Growth hormonerelated body composition therapy Tesamorelin Appetite and weight loss medications Semaglutide, Tirzepatide Each acts on a different aspect of energy balance and body composition
Overall, this case suggests a role for prolonged fasting in combination with a GLP-1 as a bridge to bariatric surgery in carefully selected, highly-motivated patients